NCT04936009Recruiting
Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)
Noninvasive Brain Stimulation to Treat Core Social Deficits in Autism Spectrum Disorder
Source: ClinicalTrials.gov · Last updated 9 Feb 2026
Brief summary (registry, in English)
This is a randomized interventional study designed to evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on neural and behavioral facets of social cognition in adults with autism spectrum disorder (ASD).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 13 Jun 2021
- Start date
- 17 Mar 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Yale University
- Diseases
- Autism
- NCT number
- NCT04936009
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 17 Mar 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants taking prescription medications that may affect cognitive processes under study.
- Participants who have taken alcohol or recreational drugs within the preceding 24 hours.
- Participants with a history of prior TMS therapy or use of an investigational drug within 12 weeks of visit.
Other illness
- Participants reporting significant head trauma or serious brain illness.
- Participants with major psychiatric illness that would preclude completion of study measures.
- Participants with a history of serious medical illness, stroke, seizures, epileptiform EEG abnormalities, or family history of seizures.
- Participants with a history of metalworking or injury by shrapnel or metallic objects are also excluded.
Other
- Females of known/suspected pregnancy or who test positive on a pregnancy test.
- Participants with an IQ (intelligence quotient) below 80.
Who the study is looking for
- Individuals between the ages of 18 and 40 years old with typical development or with a diagnosis of autism spectrum disorder.
- Individuals able to participate in an EEG and eye-tracking experiment.
Age in the registry: 18 years to 40 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yale University Child Study Center Coordinator of this site? Confirm its status | New Haven | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.